Yukiya Narita

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 5

Top Topics

Metastatic Breast Cancer

Locally Advanced

Squamous Cell Carcinoma

Top Venues

Future oncology (London, England)

Journal of clinical medicine

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Akinobu Nakata, Naoya Hashimoto, Yukiya Narita, Munehiro Wakabayashi, Hiroyuki Kodama, Takatsugu Ogata, Kazunori Honda, Toshiki Masuishi, Hiroya Taniguchi, Shigenori Kadowaki, Masashi Ando, Yuka Endo, Haruru Kotani, Ayumi Kataoka, Masaya Hattori, Akiyo Yoshimura, Masataka Sawaki, Kazuki Nozawa, Isao Oze, Hiroji Iwata, Kei Muro
Safety of a short-term infusion of fosnetupitant in patients with gastrointestinal and breast cancer: a prospective study. The oncologist (2024)
Yukiya Narita, Kei Muro
Updated Immunotherapy for Gastric Cancer. Journal of clinical medicine 12 (7) (2023)
Takuro Mizukami, Tempei Miyaji, Yukiya Narita, Tomohiro Matsushima, Takashi Ogura, Hiromichi Miyagaki, Ryohei Kawabata, Yoshiki Horie, Takashi Kawaguchi, Kei Muro, Hiroki Hara, Takuhiro Yamaguchi, Takako Eguchi Nakajima
An observational study on nutrition status in gastric cancer patients receiving ramucirumab plus taxane: BALAST study. Future oncology (London, England) 17 (19) (2021)
Yukiya Narita, Hirokazu Shoji, Sadayuki Kawai, Takuro Mizukami, Michio Nakamura, Toshikazu Moriwaki, Takeharu Yamanaka, Yu Sunakawa, Hisato Kawakami, Tomohiro Nishina, Toshihiro Misumi, Kei Muro
REVIVE study: a prospective observational study in chemotherapy after nivolumab therapy for advanced gastric cancer. Future oncology (London, England) 17 (8) (2020)
Sakura Iizumi, Atsuo Takashima, Yukiya Narita, Masahiro Tajika, Kei Muro, Sadayuki Kawai, Hirofumi Yasui, Tomohiro Matsushima, Daisuke Takahari, Kengo Nagashima, Narikazu Boku
Efficacy and safety of taxane monotherapy in advanced gastric cancer refractory to triplet chemotherapy with docetaxel, cisplatin, and S-1: a multicenter retrospective study. Cancer chemotherapy and pharmacology 80 (3) (2017)